BIIB Price / FCF | BIOGEN INC.

BIOGEN INC. Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

BIOGEN INC. price-fcf ratio for the quarter ending 2026-03-31 was 11.1, a 35.00% increase year-over-year.
BIOGEN INC. price-fcf ratio for the quarter ending 2025-12-31 was 12.6, a 53.84% increase year-over-year.
BIOGEN INC. price-fcf ratio for the quarter ending 2025-09-30 was 8.91, a 38.54% decline year-over-year.
BIOGEN INC. price-fcf ratio for the quarter ending 2025-06-30 was 9.3, a 56.87% decline year-over-year.
BIOGEN INC. price-fcf ratio for fiscal 2026 was 11.1.
BIOGEN INC. price-fcf ratio for fiscal 2025 was 12.6, a 53.84% increase from fiscal 2024.
BIOGEN INC. price-fcf ratio for fiscal 2024 was 8.19, a 72.25% decline from fiscal 2023.
BIOGEN INC. price-fcf ratio for fiscal 2023 was 29.52, a 15.31% decline from fiscal 2022.

Available history: 2009-09-30 to 2026-03-31
Data captured: 2026-03-31

Historical Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-03-31	11.1	$26.89B	$2.42B
2025-12-31	12.6	$25.84B	$2.05B
2025-09-30	8.91	$20.53B	$2.3B
2025-06-30	9.3	$18.4B	$1.98B
2025-03-31	8.22	$20.03B	$2.44B
2024-12-31	8.19	$22.3B	$2.72B
2024-09-30	14.5	$28.24B	$1.95B
2024-06-30	21.57	$33.75B	$1.57B
2024-03-31	22.57	$31.34B	$1.39B
2023-12-31	29.52	$37.5B	$1.27B
2023-09-30	35.06	$37.22B	$1.06B
2023-06-30	36	$41.23B	$1.15B
2023-03-31	28.12	$40.17B	$1.43B
2022-12-31	34.86	$39.88B	$1.14B
2022-09-30	17.67	$38.75B	$2.19B
2022-06-30	12.69	$29.87B	$2.35B
2022-03-31	11.02	$30.95B	$2.81B
2021-12-31	10.43	$35.27B	$3.38B
2021-09-30	19.69	$42.17B	$2.14B
2021-06-30	21.06	$52.13B	$2.48B
2021-03-31	13.47	$42.62B	$3.16B
2020-12-31	9.81	$37.32B	$3.81B
2020-09-30	7.35	$44.91B	$6.11B
2020-06-30	6.6	$43.66B	$6.62B
2020-03-31	8.41	$55.07B	$6.55B
2019-12-31	7.87	$51.69B	$6.56B
2019-09-30	6.73	$42.94B	$6.38B
2019-06-30	7.14	$45.35B	$6.35B
2019-03-31	8.47	$46.5B	$5.49B
2018-12-31	10.95	$59.34B	$5.42B
2018-09-30	14.13	$71.17B	$5.04B
2018-06-30	12.6	$61.24B	$4.86B
2018-03-31	11.77	$57.93B	$4.92B
2017-12-31	18.29	$67.38B	$3.68B
2017-09-30	17.44	$66.2B	$3.8B
2017-06-30	17.89	$57.56B	$3.22B
2017-03-31	19	$59.05B	$3.11B
2016-12-31	15.42	$61.22B	$3.97B
2016-09-30	18.9	$68.59B	$3.63B
2016-06-30	15.25	$52.97B	$3.47B
2016-03-31	16.13	$56.92B	$3.53B
2015-12-31	20.44	$66.97B	$3.28B
2015-09-30	22.54	$68.62B	$3.04B
2015-06-30	29.42	$95.02B	$3.23B
2015-03-31	30.58	$99.06B	$3.24B
2014-12-31	30	$79.63B	$2.65B
2014-09-30	29.83	$78.12B	$2.62B
2014-06-30	31.7	$74.79B	$2.36B
2014-03-31	36.09	$72.31B	$2B
2013-12-31	31.48	$66.07B	$2.1B
2013-09-30	32.75	$57.22B	$1.75B
2013-06-30	31.16	$51.08B	$1.64B
2013-03-31	27.91	$45.52B	$1.63B
2012-12-31	21.31	$34.63B	$1.63B
2012-09-30	22.18	$35.27B	$1.59B
2012-06-30	21.28	$34.59B	$1.63B
2012-03-31	20.91	$30.08B	$1.44B
2011-12-31	17.53	$26.64B	$1.52B
2011-09-30	15.08	$22.59B	$1.5B
2011-06-30	18.88	$25.84B	$1.37B
2011-03-31	12.88	$17.7B	$1.37B
2010-12-31	11.11	$16.13B	$1.45B
2010-09-30	10.5	$13.58B	$1.29B
2010-06-30	11.19	$12.67B	$1.13B
2010-03-31	16.39	$15.47B	$944.23M
2009-12-31	0.02	$14.7M	$909.25M
2009-09-30	14.05	$14.59B	$1.04B

Annual Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-03-31	11.1	$26.89B	$2.42B
2025-12-31	12.6	$25.84B	$2.05B
2024-12-31	8.19	$22.3B	$2.72B
2023-12-31	29.52	$37.5B	$1.27B
2022-12-31	34.86	$39.88B	$1.14B
2021-12-31	10.43	$35.27B	$3.38B
2020-12-31	9.81	$37.32B	$3.81B
2019-12-31	7.87	$51.69B	$6.56B
2018-12-31	10.95	$59.34B	$5.42B
2017-12-31	18.29	$67.38B	$3.68B
2016-12-31	15.42	$61.22B	$3.97B
2015-12-31	20.44	$66.97B	$3.28B
2014-12-31	30	$79.63B	$2.65B
2013-12-31	31.48	$66.07B	$2.1B
2012-12-31	21.31	$34.63B	$1.63B
2011-12-31	17.53	$26.64B	$1.52B
2010-12-31	11.11	$16.13B	$1.45B
2009-12-31	0.02	$14.7M	$909.25M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Revolution Medicines, Inc. (RVMD)	United States	$42.805B	-22.69
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29